Immunovia Announces Management Team Changes
LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray™ for the early detection of cancer, announced today that Dr. Peter Schultz-Knappe, Chief Technology Officer, is stepping down from his position to pursue other opportunities effective on August 31, 2020. Hans Christian Pedersen, Vice-President of Business Development, will assume Peter’s duties and become Immunovia’s Vice President of Strategy and Business Development. Hans Christian’s expanded